澳門:截至今早九時止全民核檢逾48萬人呈陰性 共16個10混1樣本初檢呈陽性
澳門特區新型冠狀病毒感染應變協調中心表示,今次全民核酸檢測於6月19日中午12時開始,截至今日(21日)早上9時,已採樣65.44萬人次,其中48.87萬人次已有檢測結果,呈陰性;另外,全民核酸檢測至早上9時累計共16個10混1樣本初檢呈陽性。
應變協調中心強調,是次全民核酸檢測今日中午12時結束,所有臨時核檢站隨即關閉。若在今日下午3時前仍然未進行核酸檢測的市民,其健康碼將被轉為黃碼,必須接受核酸檢測並有陰性結果後才轉為綠碼。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.